ZOOMCAR HOLDINGS INC (ZCAR) Fundamental Analysis & Valuation

NASDAQ:ZCAR • US45784G3092

Current stock price

4.95 USD
-1 (-16.81%)
At close:
5 USD
+0.05 (+1.01%)
After Hours:

This ZCAR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ZCAR Profitability Analysis

1.1 Basic Checks

  • In the past year ZCAR has reported negative net income.
  • ZCAR had a negative operating cash flow in the past year.
ZCAR Yearly Net Income VS EBIT VS OCF VS FCFZCAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • ZCAR has a worse Return On Assets (-265.75%) than 92.68% of its industry peers.
Industry RankSector Rank
ROA -265.75%
ROE N/A
ROIC N/A
ROA(3y)-125.24%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZCAR Yearly ROA, ROE, ROICZCAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

  • The Gross Margin of ZCAR (32.93%) is worse than 60.98% of its industry peers.
  • The Profit Margin and Operating Margin are not available for ZCAR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZCAR Yearly Profit, Operating, Gross MarginsZCAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. ZCAR Health Analysis

2.1 Basic Checks

  • ZCAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ZCAR has been reduced compared to 1 year ago.
  • ZCAR has a worse debt/assets ratio than last year.
ZCAR Yearly Shares OutstandingZCAR Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
ZCAR Yearly Total Debt VS Total AssetsZCAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • ZCAR has an Altman-Z score of -63.11. This is a bad value and indicates that ZCAR is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of ZCAR (-63.11) is worse than 95.12% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -63.11
ROIC/WACCN/A
WACC5.95%
ZCAR Yearly LT Debt VS Equity VS FCFZCAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • ZCAR has a Current Ratio of 0.11. This is a bad value and indicates that ZCAR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.11, ZCAR is not doing good in the industry: 95.12% of the companies in the same industry are doing better.
  • ZCAR has a Quick Ratio of 0.11. This is a bad value and indicates that ZCAR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ZCAR's Quick ratio of 0.11 is on the low side compared to the rest of the industry. ZCAR is outperformed by 95.12% of its industry peers.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11
ZCAR Yearly Current Assets VS Current LiabilitesZCAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ZCAR Growth Analysis

3.1 Past

  • The earnings per share for ZCAR have decreased strongly by -212.06% in the last year.
  • ZCAR shows a strong growth in Revenue. In the last year, the Revenue has grown by 276.54%.
EPS 1Y (TTM)-212.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.53%
Revenue 1Y (TTM)276.54%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.16%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZCAR Yearly Revenue VS EstimatesZCAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2M 4M 6M 8M

More info and screens

Find the best growth stocksShow best growing peers

0

4. ZCAR Valuation Analysis

4.1 Price/Earnings Ratio

  • ZCAR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZCAR Price Earnings VS Forward Price EarningsZCAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZCAR Per share dataZCAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20 -30 -40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ZCAR Dividend Analysis

5.1 Amount

  • ZCAR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ZCAR Fundamentals: All Metrics, Ratios and Statistics

ZOOMCAR HOLDINGS INC

NASDAQ:ZCAR (5/7/2025, 8:00:02 PM)

After market: 5 +0.05 (+1.01%)

4.95

-1 (-16.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners1.06%
Inst Owner Change-0.42%
Ins Owners3.83%
Ins Owner Change0%
Market Cap3.51M
Revenue(TTM)9.12M
Net Income(TTM)-21.32M
AnalystsN/A
Price TargetN/A
Short Float %4.37%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.39
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-23.41
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-26.45
FCFYN/A
OCF(TTM)-26.34
OCFYN/A
SpS12.84
BVpS-44.32
TBVpS-44.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -265.75%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.93%
FCFM N/A
ROA(3y)-125.24%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z -63.11
F-Score4
WACC5.95%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-212.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)276.54%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1496.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1489.12%
OCF growth 3YN/A
OCF growth 5YN/A

ZOOMCAR HOLDINGS INC / ZCAR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ZOOMCAR HOLDINGS INC (ZCAR) stock?

ChartMill assigns a fundamental rating of 0 / 10 to ZCAR.


Can you provide the valuation status for ZOOMCAR HOLDINGS INC?

ChartMill assigns a valuation rating of 0 / 10 to ZOOMCAR HOLDINGS INC (ZCAR). This can be considered as Overvalued.


Can you provide the profitability details for ZOOMCAR HOLDINGS INC?

ZOOMCAR HOLDINGS INC (ZCAR) has a profitability rating of 0 / 10.


How financially healthy is ZOOMCAR HOLDINGS INC?

The financial health rating of ZOOMCAR HOLDINGS INC (ZCAR) is 0 / 10.